ArticleOncoTargets and therapy2015
Erratum: Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era [Corrigendum].
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.